Indeed, one of these studies even identified differences in the evolution of TMPRSS2-ERG+ vs. TMPRSS2-ERG− prostate cancers, based on whole genome sequencing of 112 primary and metastatic prostate tumours [29]. Here, TMPRSS2 is linked to prostate carcinoma.